Q1 2026 Genomma Lab Internacional SAB de CV Earnings Call Transcript
Key Points
- LatAm continues to deliver solid results with a 5.3% like-for-like sales growth.
- Gross margin expanded by 61 basis points to 63.4%, reflecting productivity gains.
- Genomma Lab Mexico is showing early signs of market share recovery across key categories.
- The company is launching new products and expanding distribution channels, including 430 new routes and 138,000 new points of sales.
- E-commerce is expected to grow by 30% in 2026, contributing significantly to consolidated sales.
- Net sales declined by 4.9% due to a weak consumption environment in Mexico and disruptions in the US Hispanic market.
- EBITDA margin declined by 96 basis points to 22.8% due to operating deleverage and increased investment.
- Mexico, representing 45% of the business, saw a 5.8% decline in sellout.
- The Mexican peso's appreciation created significant FX headwinds, impacting international revenue consolidation.
- Short-term EBITDA margin pressure is expected as the company prioritizes market share defense amid increased competition.
Good day, ladies and gentlemen. Thank you for joining Genomma Lab's first quarter 2026 earnings conference call. (Operator Instructions) As a reminder, this meeting is being recorded and will be available for replay from the Investor Relations section of Genomma's website following the call.
I'll now turn the call over to Christianne Ibanez, Genomma's Head of Investor Relations. Please go ahead.
Thank you, and welcome, everyone. On today's call are Marco Sparvieri, Chief Executive Officer; and Antonio Zamor, Chief Financial Officer.
Before we get started, I'd like to remind you that the remarks today will include forward-looking statements, such as the company's financial guidance and expectations including long-term objectives and forecasts as well as expectations regarding Genomma's business, products, strategies, demand and markets. These statements are subject to risks and uncertainties that could cause actual results to differ materially. They are also
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
